Abstract

This task order is to evaluate preclinical efficacy of ActoPlus/Met in preventing breast cancer in the methylnitrosourea (ER+) mammary cancer model (using a high-fat diet to mimic obesity/insulin resistance), and in the MMTV/Neu (ER-) mammary gland carcinogenesis model (using a high fat diet to mimic obesity).

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
261201200021I-0-26100006-1
Application #
8945320
Study Section
Project Start
2014-08-26
Project End
2016-08-25
Budget Start
Budget End
Support Year
Fiscal Year
2014
Total Cost
Indirect Cost

  Institution

Name
University of Alabama Birmingham
Department
Type
DUNS #
City
Birmingham
State
AL
Country
United States
Zip Code
35294